Literature DB >> 18028998

Leukotriene D(4) induces gene expression in human monocytes through cysteinyl leukotriene type I receptor.

Grzegorz Woszczek1, Li-Yuan Chen, Sahrudaya Nagineni, Steven Kern, Jennifer Barb, Peter J Munson, Carolea Logun, Robert L Danner, James H Shelhamer.   

Abstract

BACKGROUND: Cysteinyl leukotrienes (CysLTs) are important mediators of innate immune responsiveness and chronic inflammatory diseases. CysLTs acting through CysLT receptors can influence the migration and activity of cells, such as eosinophils, monocytes, and dendritic cells.
OBJECTIVE: We sought to determine the gene expression signature of human monocytes in response to CysLTs and to elucidate the signaling pathways involved in monocyte activation.
METHODS: Gene expression was analyzed by using oligonucleotide microarrays. Responsiveness to CysLTs was assessed by using real-time PCR, calcium flux, kinase activation, and chemotaxis assays.
RESULTS: CysLT type 1 receptor (CysLTR(1)) transcript 1 is predominantly expressed in human monocytes, and CysLTs signal through CysLTR(1) in these cells. Several immediate-early genes, including early growth response 2 and 3, FBJ murine osteosarcoma viral oncogene homolog B, activating transcription factor 3, and nuclear receptor subfamily 4 were significantly induced by leukotriene (LT) D(4). This effect was mediated by CysLTR(1) coupled to the G protein alpha inhibitory subunit, activation of phospholipase C, and inositol-1,4,5-triphosphate and store-operated calcium channels. LTD(4) induced p38 mitogen-activated protein kinase phosphorylation, a pathway also involved in the regulation of immediate-early gene expression in monocytes. LTD(4) stimulated monocyte chemotactic activity that was fully blocked by a selective CysLTR(1) inhibitor, MK571, and pertussis toxin, suggesting that CysLTR(1) coupled to the G protein alpha inhibitory subunit is a dominant functional pathway in human monocytes.
CONCLUSION: Our data show that CysLTs acting through CysLTR(1) can significantly influence the activation and migration of human monocytes and that these effects can be fully inhibited by CysLTR(1) antagonists.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18028998      PMCID: PMC5560436          DOI: 10.1016/j.jaci.2007.09.013

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  30 in total

1.  IFN-gamma induces cysteinyl leukotriene receptor 2 expression and enhances the responsiveness of human endothelial cells to cysteinyl leukotrienes.

Authors:  Grzegorz Woszczek; Li-Yuan Chen; Sahrudaya Nagineni; Sara Alsaaty; Anya Harry; Carolea Logun; Rafal Pawliczak; James H Shelhamer
Journal:  J Immunol       Date:  2007-04-15       Impact factor: 5.422

2.  Chemotaxis and transendothelial migration of CD34(+) hematopoietic progenitor cells induced by the inflammatory mediator leukotriene D4 are mediated by the 7-transmembrane receptor CysLT1.

Authors:  F Bautz; C Denzlinger; L Kanz; R Möhle
Journal:  Blood       Date:  2001-06-01       Impact factor: 22.113

3.  Cysteinyl leukotrienes induce human eosinophil locomotion and adhesion molecule expression via a CysLT1 receptor-mediated mechanism.

Authors:  L Fregonese; M Silvestri; F Sabatini; G A Rossi
Journal:  Clin Exp Allergy       Date:  2002-05       Impact factor: 5.018

4.  IL-13 and IL-4 up-regulate cysteinyl leukotriene 1 receptor expression in human monocytes and macrophages.

Authors:  M Thivierge; J Stanková; M Rola-Pleszczynski
Journal:  J Immunol       Date:  2001-09-01       Impact factor: 5.422

Review 5.  Leukotrienes: underappreciated mediators of innate immune responses.

Authors:  Marc Peters-Golden; Claudio Canetti; Peter Mancuso; Michael J Coffey
Journal:  J Immunol       Date:  2005-01-15       Impact factor: 5.422

6.  Activation of the protein kinase ERK5/BMK1 by receptor tyrosine kinases. Identification and characterization of a signaling pathway to the nucleus.

Authors:  S Kamakura; T Moriguchi; E Nishida
Journal:  J Biol Chem       Date:  1999-09-10       Impact factor: 5.157

7.  Pranlukast, a cysteinyl leukotriene receptor antagonist, attenuates allergen-induced early- and late-phase bronchoconstriction and airway hyperresponsiveness in asthmatic subjects.

Authors:  A Hamilton; I Faiferman; P Stober; R M Watson; P M O'Byrne
Journal:  J Allergy Clin Immunol       Date:  1998-08       Impact factor: 10.793

Review 8.  Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodeling.

Authors:  Stephen T Holgate; Marc Peters-Golden; Reynold A Panettieri; William R Henderson
Journal:  J Allergy Clin Immunol       Date:  2003-01       Impact factor: 10.793

Review 9.  Cysteinyl leukotrienes and their receptors: cellular distribution and function in immune and inflammatory responses.

Authors:  Yoshihide Kanaoka; Joshua A Boyce
Journal:  J Immunol       Date:  2004-08-01       Impact factor: 5.422

10.  CysLT1 signal transduction in differentiated U937 cells involves the activation of the small GTP-binding protein Ras.

Authors:  Valérie Capra; Saula Ravasi; Maria Rosa Accomazzo; Marco Parenti; G Enrico Rovati
Journal:  Biochem Pharmacol       Date:  2004-04-15       Impact factor: 5.858

View more
  23 in total

1.  Discovery of 3-Substituted 1H-Indole-2-carboxylic Acid Derivatives as a Novel Class of CysLT1 Selective Antagonists.

Authors:  Huayan Chen; Hui Yang; Zhilong Wang; Xin Xie; Fajun Nan
Journal:  ACS Med Chem Lett       Date:  2016-01-22       Impact factor: 4.345

2.  A compendium of monocyte transcriptome datasets to foster biomedical knowledge discovery.

Authors:  Darawan Rinchai; Sabri Boughorbel; Scott Presnell; Charlie Quinn; Damien Chaussabel
Journal:  F1000Res       Date:  2016-03-07

3.  Activation of the transcription factor FosB/activating protein-1 (AP-1) is a prominent downstream signal of the extracellular nucleotide receptor P2RX7 in monocytic and osteoblastic cells.

Authors:  Monica L Gavala; Lindsay M Hill; Lisa Y Lenertz; Maya R Karta; Paul J Bertics
Journal:  J Biol Chem       Date:  2010-09-02       Impact factor: 5.157

4.  Concentration-dependent noncysteinyl leukotriene type 1 receptor-mediated inhibitory activity of leukotriene receptor antagonists.

Authors:  Grzegorz Woszczek; Li-Yuan Chen; Sara Alsaaty; Sahrudaya Nagineni; James H Shelhamer
Journal:  J Immunol       Date:  2010-01-18       Impact factor: 5.422

5.  A role for inflammatory mediators in heterologous desensitization of CysLT1 receptor in human monocytes.

Authors:  Valérie Capra; Maria Rosa Accomazzo; Fabrizio Gardoni; Silvia Barbieri; G Enrico Rovati
Journal:  J Lipid Res       Date:  2009-11-15       Impact factor: 5.922

6.  IL-10 inhibits cysteinyl leukotriene-induced activation of human monocytes and monocyte-derived dendritic cells.

Authors:  Grzegorz Woszczek; Li-Yuan Chen; Sahrudaya Nagineni; James H Shelhamer
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

Review 7.  Expanding roles for leukotrienes in airway inflammation.

Authors:  Marc Peters-Golden
Journal:  Curr Allergy Asthma Rep       Date:  2008-07       Impact factor: 4.806

8.  Dectin-2 recognition of house dust mite triggers cysteinyl leukotriene generation by dendritic cells.

Authors:  Nora A Barrett; Akiko Maekawa; Opu M Rahman; K Frank Austen; Yoshihide Kanaoka
Journal:  J Immunol       Date:  2009-01-15       Impact factor: 5.422

9.  p38alpha MAP kinase C-terminal domain binding pocket characterized by crystallographic and computational analyses.

Authors:  J Jefferson P Perry; Rodney M Harris; Davide Moiani; Arthur J Olson; John A Tainer
Journal:  J Mol Biol       Date:  2009-06-06       Impact factor: 5.469

10.  Variable expression of cysteinyl leukotriene type I receptor splice variants in asthmatic females with different promoter haplotypes.

Authors:  Milena Sokolowska; Karolina Wodz-Naskiewicz; Malgorzata Cieslak; Karolina Seta; Andrzej K Bednarek; Rafal Pawliczak
Journal:  BMC Immunol       Date:  2009-12-15       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.